Identifying controlled substance patterns of utilization requiring evaluation using administrative claims data

American Journal of Managed Care

Volumn 10, Issue 11 I, 2004, Pages 783-790

  Parente, Stephen T ^a,b   Kim, Susan S ^d   Finch, Michael D ^c   Schloff, Lisa A ^a   Rector, Thomas S ^c   Seifeldin, Raafat ^d   Haddox, J David ^d,e  

^a HSI Network LLC   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c Center for Health Care Policy and Evaluation   (United States)

^d PURDUE PHARMA L P   (United States)

^e UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; BENZODIAZEPINE; BUTORPHANOL; BUTORPHANOL TARTRATE; CARISOPRODOL; CLONAZEPAM; DIAZEPAM; OPIATE; PARACETAMOL; PETHIDINE;

ADULT; ARTICLE; COMPUTER PROGRAM; DRUG ABUSE PATTERN; DRUG MISUSE; DRUG SURVEILLANCE PROGRAM; DRUG USE; HEALTH INSURANCE; HUMAN; INSURANCE; MULTIPLE DRUG ABUSE; PHARMACY; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SUBSTANCE ABUSE;

ADOLESCENT; ADULT; ANALGESICS, OPIOID; BENZODIAZEPINES; BUTORPHANOL; CARISOPRODOL; CLINICAL PHARMACY INFORMATION SYSTEMS; DATABASES; DRUG AND NARCOTIC CONTROL; DRUG UTILIZATION REVIEW; HUMANS; INSURANCE CLAIM REVIEW; MANAGED CARE PROGRAMS; MIDDLE AGED; PAIN; PATTERN RECOGNITION, AUTOMATED; PRESCRIPTIONS, DRUG; PREVALENCE; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 8744264008     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Hoffmann DE, Tarzian AJ. Achieving the right balance in oversight of physician opioid prescribing for pain: the role of state medical boards. J Law Med Ethics. 2003;31:21-40.
2. American Pain Society Web site. Promoting pain relief and preventing abuse of pain medications: a critical balancing act: a joint statement from 21 health organizations and the Drug Enforcement Administration. 2001. Available at: http://www.ampainsoc.org/advocacy/promoting.htm. Accessed Febuary 20, 2002.
3. Zacny J, Bigelow G, Compton P, Foley K, Iguchi M, Sannerud C. College on Problems of Drug Dependence taskforce on prescription opioid non-medical use and abuse: position statement. Drug Alcohol Depend. 2003;69:215-232.
4. American Pain Society. Principles of Analgesic Use in the Treatment of Acute Pain and Cancer Pain. 4th ed. Glenview, Ill: American Pain Society; 1999.
5. Jacox A, Carr DN, Payne R, et al. Management of Cancer Pain: Clinical Practice Guideline No. 9. Rockville, Md: Agency for Health Care Policy and Research, US Dept of Health and Human Services, Public Health Service; March 1994. AHCPR publication 94-0592.
6. American Pain Society Web site. The use of opioids for the treatment of chronic pain: a consensus statement from American Academy of Pain Medicine and American Pain Society. 1997. Available at: http://www.ampainsoc.org/advocacy/ opioids.htm. Accessed February 20, 2002.
7. American Pain Society. Guideline for the Management of Pain in Osteoarthritis, Rheumatoid Arthritis and Juvenile Chronic Arthritis: Clinical Practice Guideline No. 2. Glenview, Ill: American Pain Society; 2002.
8. American Geriatrics Society Panel on Persistent Pain in Older Persons. The management of persistent pain in older persons. J Am Geriatr Soc. 2002;50(suppl 6):S205-S224.
9. American Medical Association Web site. Report 11 of the Council on Scientific Affairs (A-99): use of opioids in chronic noncancer pain. 1999. Available at: http://www.ama-assn.org/ama/pub/article/2036-2341.html. Accessed March 1, 2002.
10. Dickinson BD, Altman RD, Nielsen NH, Williams MA. Use of opioids to treat chronic, noncancer pain. West J Med. 2000;172:107-115.
11. American Pain Society. Guideline for the Management of Acute and Chronic Pain in Sickle-Cell Disease: Clinical Practice Guideline No. 1. Glenview, Ill: American Pain Society; 1999.
12. Gilson AM, Joranson DE, Maurer MA. Improving state medical board policies: influence of a model. J Law Med Ethics. 2003;31:119-129.
13. Federation of State Medical Boards Web of the United States, Inc. Model Policy for the Use of Controlled Substances for the Treatment of Pain. May 2004. Available at: http://www.fsmb.org. Accessed October 1, 2004.
14. Dahl JL, Bennett ME, Bromley MD, Joranson DE. Success of the state pain initiatives: moving pain management forward. Cancer Pract. 2002;10(suppl 1):S9-S13.
15. Jacob E, American Pain Society. Pain management in sickle cell disease. Pain Manag Nurs. 2001;2:121-131.
16. Katz WA. Musculoskeletal pain and its socioeconomic implications. Clin Rheumatol. 2002;21(suppl 1):S2-S4.
17. Anderson KO, Richman SP, Hurley J, et al. Cancer pain management among underserved minority outpatients: perceived needs and barriers to optimal control. Cancer. 2002;94:2295-2304.
18. Robeznieks A. Pain specialists fear chilling effect after arrest. October 27, 2003. Available at: http://www.ama-assn.org/amednews/2003/10/27/prsc1027. htm. Accessed February 20, 2004.
19. Savage SR. Assessment for addiction in pain-treatment settings. Clin J Pain. 2002;18(suppl 4):S28-S38.
20. Kohn LT, Corrigan JM, Donaldson MS, Committee on Quality of Health Care in America, Institute of Medicine, eds. To Err Is Human: Building a Safer Health System. Washington, DC: National Academy Press; 1999.
21. Ziegler SJ, Lovrich NP Jr. Pain relief, prescription drugs, and prosecution: a four-state survey of chief prosecutors. J Law Med Ethics. 2003;31:75-100.
22. Joranson DE, Carrow GM, Ryan KM, et al. Pain management and prescription monitoring. J Pain Symptom Manage. 2002;23:231-238.
23. Forgione DA, Neuenschwander P, Vermeer TE. Diversion of prescription drugs to the black market: what the states are doing to curb the tide. J Health Care Finance. 2001;27:65-78.
24. US General Accounting Office Report to the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives. Prescription Drugs: State Monitoring Programs Provide Useful Tool to Reduce Diversion. Washington, DC: US General Accounting Office; May 2002. Publication CAO-02-634.
25. US Department of Justice, Drug Enforcement Administration, Diversion Control Program. Diversion and Abuse of Prescription Drugs: A Closer Look at State Prescription Monitoring Programs. Alexandria, Va: Drug Enforcement Administration; April 2000.
26. Brushwood DB. Maximizing the value of electronic prescription monitoring programs. J Law Med Ethics. 2003;31:41-54.
27. Weiner JP, Starfield BH, Steinwachs DM, Mumford LM. Development and application of a population-oriented measure of ambulatory care case-mix. Med Care. 1991;29:452-472.
28. Armstrong EP, Manuchehri F. Ambulatory care databases for managed care organizations. Am J Health Syst Pharm. 1997;54:1973-1983.
29. Weiner JP, Powe NR, Steinwachs DM, Dent G. Applying insurance claims data to assess quality of care: a comparison of potential indicators. QRB Qual Rev Bull. 1990;16:424-438.
30. Drug Abuse Warning Network Web site. Emergency department trends from DAWN: final estimates 1994 to 2001. August 2002. DAWN Series, No. D-21. DHHS publication SMA-02-3635. Available at: http://dawninfo.samhsa.gov/pubs_94_02/ edpubs/2001final/default.asp. Accessed October 10, 2003.
31. Hofer TP, Hayward RA, Greenfield S, Wagner EH, Kaplan SH, Manning WG. The unreliability of individual physician "report cards" for assessing the costs and quality of care of a chronic disease. JAMA. 1999;281:2098-2105.
32. Deyo RA, Taylor VM, Diehr P, et al. Analysis of automated administrative and survey databases to study patterns and outcomes of care. Spine. 1994;19(suppl):2083S-2091S.